Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E-Rx, Dialysis Bundling Are Likely Survivors Of Failed Medicare Doc Fix Bill

Executive Summary

Electronic prescribing is among the handful of drug-related items likely to be revived when Finance Committee Chairman Max Baucus, D-Mont., recrafts his Medicare physician payment package to gain broader Senate support

You may also be interested in...



Medicare Bill Strikes Out Again In Senate After Home Run In House

Momentum from a surprising House passage of a slightly modified version of the Sen. Max Baucus-penned Medicare physician payment legislation was not quite enough to carry the bill on a second try in the Senate on June 26

Medicare Bill Strikes Out Again In Senate After Home Run In House

Momentum from a surprising House passage of a slightly modified version of the Sen. Max Baucus-penned Medicare physician payment legislation was not quite enough to carry the bill on a second try in the Senate on June 26

AMA wants carrots, but not sticks, for e-prescribing

The American Medical Association should lobby against any legislation that would reduce Medicare or Medicaid payments to physicians who do not adopt electronic prescribing, the group's House of Delegates resolved during their June 14-18 annual meeting. Medicare bonuses for adopting e-prescribing and penalties for not using it are a key element of separate Medicare physician bills drafted by both Senate Finance Committee Chairman Max Baucus, D-Mont., and Ranking Member Chuck Grassley, Iowa (1"The Pink Sheet," June 16, 2008, p. 10). While not actively endorsing e-prescribing, the delegates agreed to advocate financial and other incentives for adoption and efforts to remove barriers to its use, such DEA prohibitions on e-prescribing of controlled substances and a Medicaid requirement that physicians write in their own hand when a brand drug is medically necessary. The physician group also resolves to work with federal and private entities to ensure universal acceptance of electronic prescriptions by pharmacies

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel